Sg3 Management, LLC Biomarin Pharmaceutical Inc Put Options Transaction History

Sg3 Management, LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 15, 2022	SELL	$71.48 - $86.85 $1.82 Million - $2.21 Million	-25,400 Reduced 50.4%	25,000 $2.07 Million
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $1.52 Million - $1.89 Million	20,400 Added 68.0%	50,400 $3.89 Million
Q4 2021 Feb 15, 2022	SELL	$71.72 - $91.47 $1.61 Million - $2.06 Million	-22,500 Reduced 42.86%	30,000 $2.65 Million
Q3 2021 Nov 15, 2021	BUY	$74.77 - $85.47 $657,976 - $752,136	8,800 Added 20.14%	52,500 $4.06 Million
Q2 2021 Aug 16, 2021	SELL	$75.51 - $84.79 $98,163 - $110,227	-1,300 Reduced 2.89%	43,700 $3.65 Million
Q1 2021 May 17, 2021	SELL	$74.73 - $90.69 $10.8 Million - $13.1 Million	-144,800 Reduced 76.29%	45,000 $3.4 Million
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $12.7 Million - $15.8 Million	174,800 Added 1165.33%	189,800 $16.6 Million
Q3 2020 Nov 13, 2020	BUY	$71.87 - $131.03 $1.08 Million - $1.97 Million	15,000 New	15,000 $1.14 Million

635

178M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.